Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Covington
Farmers Insurance
Accenture
Medtronic
Chinese Patent Office
Cerilliant
Baxter
Deloitte

Generated: January 21, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019970

« Back to Dashboard

NDA 019970 describes NITROGLYCERIN IN DEXTROSE 5%, which is a drug marketed by Baxter Hlthcare and Hospira and is included in five NDAs. It is available from two suppliers. Additional details are available on the NITROGLYCERIN IN DEXTROSE 5% profile page.

The generic ingredient in NITROGLYCERIN IN DEXTROSE 5% is nitroglycerin. There are thirty-six drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the nitroglycerin profile page.
Summary for 019970
Tradename:NITROGLYCERIN IN DEXTROSE 5%
Applicant:Baxter Hlthcare
Ingredient:nitroglycerin
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 019970
Physiological EffectVasodilation
Medical Subject Heading (MeSH) Categories for 019970
Suppliers and Packaging for NDA: 019970
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NITROGLYCERIN IN DEXTROSE 5% nitroglycerin INJECTABLE;INJECTION 019970 NDA Baxter Healthcare Company 0338-1047 0338-1047-02 12 BOTTLE, GLASS in 1 BOX (0338-1047-02) > 250 mL in 1 BOTTLE, GLASS
NITROGLYCERIN IN DEXTROSE 5% nitroglycerin INJECTABLE;INJECTION 019970 NDA Baxter Healthcare Company 0338-1049 0338-1049-02 12 BOTTLE, GLASS in 1 BOX (0338-1049-02) > 250 mL in 1 BOTTLE, GLASS

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength10MG/100ML
Approval Date:Dec 29, 1989TE:APRLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength20MG/100ML
Approval Date:Dec 29, 1989TE:APRLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength40MG/100ML
Approval Date:Dec 29, 1989TE:APRLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Fish and Richardson
Teva
Fuji
Moodys
Cipla
Cantor Fitzgerald
Federal Trade Commission
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.